ASX - Delayed Quote AUD
Resonance Health Limited (RHT.AX)
0.0400
0.0000
(0.00%)
As of 12:14:32 PM GMT+10. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
8,589.4900
8,589.4900
4,404.3600
3,827.9760
3,778.9140
Gross Profit
8,589.4900
8,589.4900
4,404.3600
3,827.9760
3,778.9140
Operating Expense
9,468.9630
9,468.9630
6,029.2110
5,600.4230
3,590.7240
Operating Income
-879.4730
-879.4730
-1,624.8510
-1,772.4470
188.1900
Net Non Operating Interest Income Expense
137.8340
137.8340
39.8990
3.3230
37.4820
Other Income Expense
114.7500
114.7500
320.8960
217.6020
117.8520
Pretax Income
-626.8890
-626.8890
-1,264.0560
-1,551.5220
343.5240
Tax Provision
-796.1920
-796.1920
-483.6950
-409.7450
-242.3340
Net Income Common Stockholders
169.3030
169.3030
-780.3610
-1,141.7770
585.8580
Basic EPS
0.00
0.00
-0.00
-0.00
0.00
Diluted EPS
0.00
0.00
-0.00
-0.00
0.00
Basic Average Shares
456,064.3690
456,064.3690
461,149.6010
461,149.6010
450,260.2000
Diluted Average Shares
456,064.3690
456,064.3690
461,149.6010
461,149.6010
450,260.2000
Net Income from Continuing & Discontinued Operation
169.3030
169.3030
-780.3610
-1,141.7770
585.8580
Normalized Income
169.3030
169.3030
-760.9393
-1,141.7770
585.8580
Interest Income
137.8340
137.8340
39.8990
3.3230
37.4820
Net Interest Income
137.8340
137.8340
39.8990
3.3230
37.4820
EBIT
-879.4730
-879.4730
-1,624.8510
-1,772.4470
188.1900
EBITDA
-381.5270
-381.5270
-1,188.4920
-1,343.3410
552.3490
Reconciled Depreciation
497.9460
497.9460
436.3590
429.1060
364.1590
Net Income from Continuing Operation Net Minority Interest
169.3030
169.3030
-780.3610
-1,141.7770
585.8580
Total Unusual Items Excluding Goodwill
--
--
-31.4600
--
--
Total Unusual Items
--
--
-31.4600
--
--
Normalized EBITDA
-381.5270
-381.5270
-1,157.0320
-1,343.3410
552.3490
Tax Rate for Calcs
0.0003
0.0003
0.0004
0.0003
0.0003
Tax Effect of Unusual Items
--
--
-12.0383
--
--
6/30/2021 - 1/28/1988
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade